Search form
Search
contact us
Navigation
home
boards
job center
job ratings
cp wire
device news
trending now
trending in pharma/biotech
trending in device
pharmagather
advertise
Legal Help
login/register
You are here
Home
» Pfizer downgrades Q4 outlook after $785M DOJ settlement spurred by 'serial whistleblower'
Pfizer downgrades Q4 outlook after $785M DOJ settlement spurred by 'serial whistleblower'
Pfizer downgrades Q4 outlook after $785M DOJ settlement spurred by 'serial whistleblower'
Submitted by
admin
on February 17, 2016 - 9:56pm
Source:
BioPharma Dive
News Tags:
Pfizer
DOJ
Medicaid
Wyeth
whistleblower lawsuits
Headline:
Pfizer downgrades Q4 outlook after $785M DOJ settlement spurred by 'serial whistleblower'
